Validation of a High-Quality Low-Cost Open-Source Electrocardiograph
- Conditions
- ElectrocardiographOpen AccessMedical DevicesLow Cost
- Interventions
- Device: Medical device validation
- Registration Number
- NCT04209062
- Lead Sponsor
- Lawson Health Research Institute
- Brief Summary
The high price of electrocardiograph (ECG) devices - with most hospital-grade devices costing thousands of dollars - is one of the barriers to access of this vital technology. There is a shortage of ECG devices in underserved areas and the devices available on the market currently are not adequate to solve this problem. Our solution is a low-cost high-quality open-access ECG device. This study intends to validate the study ECG device in human patients by demonstrating equivalence between the study ECG device and a gold standard device.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 450
- All study participants must be able to provide written informed consent prior to study procedure. This study has 2 Phases.
Phase 1:
- Healthy
- > 18 years of age
Phase 2:
- > 18 years of age
- non critical patients presenting to the emergency department (Victoria Hospital and University Hospital) with cardiac complaint
- < 18 years old
- Unable to consent
Phase 1:
- > 70 years of age
- Previous history of cardiac disease (e.g., atrial fibrillation, myocardial infarction, congestive heart failure)
- current status of non-sinus heart rhythm
Phase 2:
- Critical patients in the ED where consent would inappropriately delay investigations or treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Control device Medical device validation - Study device Medical device validation -
- Primary Outcome Measures
Name Time Method Equivalence of Electrical Signals between 3D printed ECG device and Gold Standard ECG 60 seconds Comparing electrical signals from ECG electrodes with tested device and gold standard device by collecting the following data from both devices: rate, QR interval, PR interval, QT interval, and rhythm.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
London Health Sciences Centre
🇨🇦London, Ontario, Canada